Pharmabiz

Emcutix Biopharma introduces SOLGLO-AZ liposomal serum for hyperpigmentation in India

Emcutix Biopharma introduces SOLGLO-AZ liposomal serum for hyperpigmentation in India: Our Bureau, Mumbai Tuesday, December 9 ...
Pharmabiz

IPC to come out with10th edition of IP to further strengthen standards of drugs in India

IPC to come out with10th edition of IP to further strengthen standards of drugs in India: Shardul Nautiyal, Mumbai Tuesday, ...
Pharmabiz

Medi Mold inks pact with OIC Intl. invests Rs. 100+ crore to set up 3D-printed orthopaedic implants production unit in Vizag

Medi Mold inks pact with OIC Intl. invests Rs. 100+ crore to set up 3D-printed orthopaedic implants production unit in Vizag: Our Bureau, Bengaluru Tuesday, December 9, 2025, 17:1 ...
Pharmabiz

Ouro Medicines’ BCMAxCD3 T cell engager antibody candidate, gamgertamig gets US FDA orphan drug designation to treat immune thrombocytopenia

Ouro Medicines’ BCMAxCD3 T cell engager antibody candidate, gamgertamig gets US FDA orphan drug designation to treat immune thrombocytopenia: South San Francisco Tuesday, Decemb ...
Pharmabiz

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces CMSF in CDKL5 deficiency disorder

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces CMSF in CDKL5 deficiency disorder: Brussels, Belgium Tuesday, December 9, 2 ...
Pharmabiz

Boehringer Ingelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development

Boehringer Ingelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development: Ingelheim, Germany Tuesday, December 9, 2025, 09:00 H ...
Pharmabiz

Metropolis granted patent for a clinician-friendly decision support system to transform TB detection and management

Metropolis granted patent for a clinician-friendly decision support system to transform TB detection and management: Our Bureau, Bengaluru Tuesday, December 9, 2025, 14:30 Hrs [IS ...
Pharmabiz

Chugai Pharma announces 48-week NIHONBASHI phase III study results presented at JRVS meeting show that Vabysmo sustained vision improvements in Japanese patients with angioid ...

Chugai Pharma announces 48-week NIHONBASHI phase III study results presented at JRVS meeting show that Vabysmo sustained vision improvements in Japanese patients with angioid streaks ...
Pharmabiz

GlycoNex inks CDMO service agreement with Change Cure to advance HMGB1-targeted antibody programme

GlycoNex inks CDMO service agreement with Change Cure to advance HMGB1-targeted antibody programme: New Taipei City, Taiwan Tuesday, December 9, 2025, 18:00 Hrs [IST] GlycoNex, In ...
Pharmabiz

Hutchmed announces expanded coverage on National Reimbursement Drug List and inclusion in the first Commercial Insurance Drug List in China

Hutchmed announces expanded coverage on National Reimbursement Drug List and inclusion in the first Commercial Insurance Drug List in China: Hong Kong, Shanghai Tuesday, December ...
Pharmabiz

Botanic Healthcare launches CornFit, a patented cornsilk-based nutraceutical extract for metabolic health

Botanic Healthcare launches CornFit, a patented cornsilk-based nutraceutical extract for metabolic health: Our Bureau, Bengaluru Tuesday, December 9, 2025, 14:45 Hrs [IST] Botanic ...
Pharmabiz

Mirum Pharma inks agreement to acquire biotech company, Bluejay Therapeutics for up to $820 million

Mirum Pharma inks agreement to acquire biotech company, Bluejay Therapeutics for up to $820 million: Foster City, California Tuesday, December 9, 2025, 14:00 Hrs [IST] Mirum Pharm ...